Discontinued — last reported Q4 '22
Roivant Sciences Interest Income decreased by 4.8% to $41.18M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.6%, from $54.62M to $41.18M. Over 2 years (FY 2023 to FY 2025), Interest Income shows an upward trend with a 10.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher interest income suggests a strong cash position or a favorable interest rate environment for the company's investments.
Interest income is the revenue earned from cash deposits, marketable securities, and other interest-bearing investments....
Varies based on cash management strategies; companies with large cash piles will report higher interest income than those with high debt.
interest_income| Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.61M | $36.61M | $36.61M | $36.61M | $72.13M | $69.77M | $61.85M | $54.62M | $48.32M | $45.34M | $43.27M | $41.18M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +97.0% | -3.3% | -11.4% | -11.7% | -11.5% | -6.2% | -4.6% | -4.8% |
| YoY Change | — | — | — | — | +97.0% | +90.6% | +69.0% | +49.2% | -33.0% | -35.0% | -30.0% | -24.6% |
| Segment | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|
| Reportable Segment | $45.34M | $43.27M | $41.18M |
| Total | $45.34M | $43.27M | $41.18M |